Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation containing same, and preparing methods and application of polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation

A technology of solid particles and protease inhibitors, which is applied in the direction of peptide/protein components, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., which can solve the problem of increasing costs, complicated preparation processes, and limited production scale and other problems, to achieve the effect of easy realization, simple preparation process and improved stability

Active Publication Date: 2018-10-16
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Generally speaking, the preparation process is relatively complicated, which limits the scale of production and increases the cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation containing same, and preparing methods and application of polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation
  • Polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation containing same, and preparing methods and application of polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation
  • Polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation containing same, and preparing methods and application of polypeptide-protein-drug-carried solid particulate matter and double-enteric solid preparation

Examples

Experimental program
Comparison scheme
Effect test

preparation Embodiment 1

[0060] Preparation Example 1 Preparation of Eudragit S100-coated insulin granules

[0061] Dissolve 100mg of SNAC in 1mL of 0.01M NaOH, and dissolve 10mg of insulin (Ins) in 1mL of 0.01M NaOH aqueous solution and add to the SNAC solution to form a homogeneous solution (A); add 500mg of Eudragit S100 to 48mL of tert-butanol medium (containing 5mL water), heated appropriately to make it fully dissolve to form a homogeneous solution (B); slowly add A to B, vortex mix at 500r / min to form a homogeneous solution, and use spray freeze-drying technology to prepare Eudragit S100 package of insulin granules.

preparation Embodiment 2

[0062] Preparation Example 2 Preparation of Eudragit S100-coated insulin granules containing protease inhibitors

[0063] Dissolve 100mg of SNAC in 1mL of 0.01M NaOH, and dissolve 10mg of Ins and 10mg of aprotinin in 1mL of 0.01M NaOH aqueous solution and add them to the SNAC solution to form a homogeneous solution (A); add 500mg of Eudragit S100 to 23mL of tert In butanol (containing 2mL water), heat appropriately to make it fully dissolve to form a homogeneous solution (B); slowly add A to B, vortex mix at 500r / min to form a homogeneous solution, and use spray freeze-drying technology to prepare Eudragit Insulin granules coated with S100.

preparation Embodiment 3

[0064] Preparation Example 3 Preparation of Eudragit S100-coated insulin granules containing protease inhibitors

[0065] Dissolve 200mg of SNAC in 1mL of 0.01M NaOH, and dissolve 10mg of Ins and 10mg of aprotinin in 1mL of 0.01M NaOH aqueous solution and add them to the SNAC solution to form a homogeneous solution (A); add 400mg of Eudragit S100 to 23mL of tert In butanol (containing 2mL water), heat appropriately to make it fully dissolve to form a homogeneous solution (B); slowly add A to B, vortex mix at 500r / min to form a homogeneous solution, and use spray freeze-drying technology to prepare Eudragit Insulin granules coated with S100.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a polypeptide-protein-drug-carried solid particulate matter and a double-enteric solid preparation containing the same, and preparing methods and application of the polypeptide-protein-drug-carried solid particulate matter and the double-enteric solid preparation. The solid particulate matter contains polypeptide protein drugs, absorption enhancers and protease inhibitors.The prepared double-enteric solid preparation can resist degradation of gastric acid and gastric intestinal enzymes to the polypeptide protein drugs during oral administration and meanwhile has the colon-specific effect, and absorption of polypeptide proteins in an intestinal tract can be effectively promoted.

Description

technical field [0001] The present invention relates to the field of biopharmaceuticals, more specifically, to a solid particle loaded with polypeptide protein drugs, a double enteric solid preparation containing the solid particle, and a preparation method and application thereof. Background technique [0002] Peptide protein drugs, such as insulin, human growth hormone, and calcitonin, are administered by injection. However, there are many disadvantages in injection administration, such as the short biological half-life of insulin, and 1-2 insulin injections per day will cause side effects such as local redness, swelling, subcutaneous nodules, subcutaneous fat atrophy, etc., which bring great pain and pain to patients. inconvenient. Therefore, research on safe, convenient, cheap and effective oral administration preparations to replace injections will greatly facilitate patients. [0003] However, if insulin and other peptide protein drugs are taken orally directly witho...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/50A61K47/32A61K47/38A61K47/18A61K38/28A61K38/22A61K38/23
CPCA61K9/0002A61K9/5015A61K9/5026A61K9/5047A61K9/5052A61K38/22A61K38/23A61K38/28
Inventor 甘勇胡磊范未伟郭仕艳朱春柳王瑞
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com